ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00246246
Recruitment Status : Completed
First Posted : October 31, 2005
Last Update Posted : February 11, 2011
Sponsor:
Information provided by:
Janssen-Ortho Inc., Canada

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : April 2006